A Phase I Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2013
At a glance
- Drugs Pacritinib (Primary)
- Indications Diffuse large B cell lymphoma; Hodgkin's disease; Lymphoma; Lymphoproliferative disorders
- Focus Adverse reactions
- 28 Jun 2013 Pooled safety results of this trial and 3 other phase I and II trials will be presented at the 18th Congress of the European Hematology Association in June 2013. Results also published in a Cell Therapeutics media release.
- 24 Sep 2012 Results were published online in the Journal of Oncology in September 2012.
- 19 Apr 2012 Actual patient number 35 added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History